Atossa Total Assets from 2010 to 2024

ATOS Stock

USD 1.22 0.03 2.52%

Atossa Genetics Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2009-12-31

Previous Quarter

85.9 M

Current Value

79.5 M

Quarterly Volatility

49.9 M

Credit Downgrade

Yuan Drop

Covid

Check Atossa Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atossa Genetics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.9 K, Interest Expense of 8.7 K or Selling General Administrative of 8.7 M, as well as many indicators such as Price To Sales Ratio of 7.6 K, Dividend Yield of 0.0 or PTB Ratio of 1.16. Atossa financial statements analysis is a perfect complement when working with Atossa Genetics Valuation or Volatility modules.

Check out the analysis of Atossa Genetics Correlation against competitors.

For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

Latest Atossa Genetics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Atossa Genetics over the last few years. Total assets refers to the total amount of Atossa Genetics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Atossa Genetics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Atossa Genetics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Atossa Genetics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 96.25 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Atossa Total Assets Regression Statistics

	Arithmetic Mean	38,893,215
	Geometric Mean	11,775,108
	Coefficient Of Variation	127.91
	Mean Deviation	41,397,864
	Median	11,764,002
	Standard Deviation	49,747,483
	Sample Variance	2474.8T
	Range	141.2M
	R-Value	0.80
	Mean Square Error	969.7T
	R-Squared	0.64
	Significance	0.0004
	Slope	8,872,373
	Total Sum of Squares	34647.4T

Atossa Total Assets History

	2024	101.1 M
	2023	96.3 M
	2022	123.5 M
	2021	141.3 M
	2020	42.8 M
	2019	14.5 M
	2018	11.7 M

Other Fundumenentals of Atossa Genetics

Intangibles To Total Assets

Atossa Genetics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Net Receivables	Short Term Investments	Intangible Assets	Property Plant Equipment	Net Tangible Assets	Capital Surpluse	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	-1.0	-0.84	0.34	1.0	-0.36	0.96	0.78	0.45	-0.31	-0.36	-0.45	0.97	0.93	0.41	0.97	0.97	0.96
Total Stockholder Equity	1.0		-1.0	-0.83	0.27	1.0	-0.34	0.95	0.76	0.44	-0.3	-0.35	-0.44	0.97	0.92	0.4	0.97	0.97	0.95
Net Debt	-1.0	-1.0		0.83	-0.34	-1.0	0.38	-0.94	-0.79	-0.48	0.3	0.39	0.46	-0.96	-0.92	-0.42	-0.96	-0.96	-0.94
Retained Earnings	-0.84	-0.83	0.83		-0.46	-0.84	0.6	-0.9	-0.66	-0.35	0.48	0.52	0.57	-0.87	-0.97	-0.65	-0.87	-0.87	-0.89
Total Liab	0.34	0.27	-0.34	-0.46		0.34	-0.28	0.36	0.57	0.31	-0.23	-0.26	-0.23	0.25	0.37	0.33	0.25	0.25	0.34
Total Current Assets	1.0	1.0	-1.0	-0.84	0.34		-0.38	0.95	0.78	0.47	-0.3	-0.39	-0.47	0.96	0.93	0.42	0.96	0.97	0.95
Short Term Debt	-0.36	-0.34	0.38	0.6	-0.28	-0.38		-0.37	-0.45	-0.38	0.25	0.72	0.3	-0.34	-0.51	-0.83	-0.35	-0.35	-0.36
Common Stock	0.96	0.95	-0.94	-0.9	0.36	0.95	-0.37		0.67	0.23	-0.28	-0.4	-0.49	0.99	0.98	0.41	0.99	0.99	1.0
Accounts Payable	0.78	0.76	-0.79	-0.66	0.57	0.78	-0.45	0.67		0.61	-0.29	-0.36	-0.29	0.64	0.67	0.5	0.65	0.65	0.67
Net Receivables	0.45	0.44	-0.48	-0.35	0.31	0.47	-0.38	0.23	0.61		-0.4	-0.3	-0.28	0.25	0.31	0.42	0.24	0.26	0.21
Short Term Investments	-0.31	-0.3	0.3	0.48	-0.23	-0.3	0.25	-0.28	-0.29	-0.4		-0.25	-0.03	-0.27	-0.39	-0.58	-0.26	-0.26	-0.27
Intangible Assets	-0.36	-0.35	0.39	0.52	-0.26	-0.39	0.72	-0.4	-0.36	-0.3	-0.25		0.63	-0.37	-0.47	-0.46	-0.38	-0.38	-0.39
Property Plant Equipment	-0.45	-0.44	0.46	0.57	-0.23	-0.47	0.3	-0.49	-0.29	-0.28	-0.03	0.63		-0.46	-0.52	-0.03	-0.47	-0.47	-0.48
Net Tangible Assets	0.97	0.97	-0.96	-0.87	0.25	0.96	-0.34	0.99	0.64	0.25	-0.27	-0.37	-0.46		0.96	0.38	1.0	1.0	0.99
Capital Surpluse	0.93	0.92	-0.92	-0.97	0.37	0.93	-0.51	0.98	0.67	0.31	-0.39	-0.47	-0.52	0.96		0.55	0.96	0.96	0.97
Current Deferred Revenue	0.41	0.4	-0.42	-0.65	0.33	0.42	-0.83	0.41	0.5	0.42	-0.58	-0.46	-0.03	0.38	0.55		0.38	0.38	0.39
Net Invested Capital	0.97	0.97	-0.96	-0.87	0.25	0.96	-0.35	0.99	0.65	0.24	-0.26	-0.38	-0.47	1.0	0.96	0.38		1.0	0.99
Net Working Capital	0.97	0.97	-0.96	-0.87	0.25	0.97	-0.35	0.99	0.65	0.26	-0.26	-0.38	-0.47	1.0	0.96	0.38	1.0		0.99
Capital Stock	0.96	0.95	-0.94	-0.89	0.34	0.95	-0.36	1.0	0.67	0.21	-0.27	-0.39	-0.48	0.99	0.97	0.39	0.99	0.99

Click cells to compare fundamentals

About Atossa Genetics Financial Statements

Atossa Genetics shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Atossa Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Atossa Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Atossa Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	96.3 M	101.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC